Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome (TB-IRIS) Treatment Trial
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01442428 |
Recruitment Status :
Withdrawn
(2011 Thailand flooding led to loss of GMP pharmacy, project delays, and further regulatory challenges.)
First Posted : September 28, 2011
Last Update Posted : November 25, 2013
|
Sponsor:
University of Minnesota
Collaborators:
Pfizer
Minnesota Medical Foundation
Information provided by (Responsible Party):
University of Minnesota
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : | Withdrawn |
---|---|
Estimated Primary Completion Date : | March 2016 |
Estimated Study Completion Date : | June 2016 |